{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:56:50Z","timestamp":1779008210834,"version":"3.51.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.transproceed.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T21:06:28Z","timestamp":1523653588000},"page":"881-883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A\u00a0Case\u00a0Report"],"prefix":"10.1016","volume":"50","author":[{"given":"M.","family":"Windpessl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Burgstaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kronbichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Pieringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Kalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Karrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.01.004_bib1","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project","volume":"113","author":"Carson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2018.01.004_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/ckj\/sfv054","article-title":"Management and prevention of post-transplant malignancies in kidney transplant recipients","volume":"8","author":"Stallone","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.transproceed.2018.01.004_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/ejh.12782","article-title":"First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study","volume":"98","author":"Mart\u00ednez-Calle","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transproceed.2018.01.004_bib4","first-page":"1","article-title":"Post-transplant lymphoproliferative disorder in adult renal transplant recipients: survival and prognosis","volume":"15","author":"Morton","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transproceed.2018.01.004_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/ajt.12153","article-title":"Progressive multifocal leukoencephalopathy in a heart transplant recipient following rituximab therapy for AMR","volume":"13","author":"Loyaga-Rendon","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.004_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00147-004-0779-3","article-title":"Progressive multifocal leukoencephalopathy in transplant recipients","volume":"17","author":"Shitrit","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2018.01.004_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.transproceed.2018.01.004_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transproceed.2018.01.004_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.autrev.2017.04.007","article-title":"Rituximab for immunologic renal disease: what the nephrologist needs to know","volume":"16","author":"Kronbichler","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transproceed.2018.01.004_bib10","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.transproceed.2018.01.004_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","article-title":"Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis","volume":"68","author":"Clifford","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.transproceed.2018.01.004_bib13","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","article-title":"Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation","volume":"86","author":"Neff","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.004_bib14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s12185-012-1118-6","article-title":"Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab","volume":"96","author":"Warsch","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transproceed.2018.01.004_bib15","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jiph.2014.11.006","article-title":"Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: a case report and literature review","volume":"8","author":"Al-Tawfiq","year":"2015","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.transproceed.2018.01.004_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archinte.1976.03630070067020","article-title":"Progressive multifocal leukoencephalopathy in renal transplant recipients","volume":"136","author":"McCormick","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transproceed.2018.01.004_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1399-3062.2009.00368.x","article-title":"Progressive multifocal leukoencephalopathy in a kidney transplant recipient after conversion to mycophenolic acid therapy","volume":"11","author":"Manfro","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.004_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/10428190902779257","article-title":"Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating","volume":"50","author":"Carson","year":"2009","journal-title":"Leuk Lymphoma"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518300332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518300332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:29:55Z","timestamp":1758576595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518300332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0041134518300332"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.004","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A\u00a0Case\u00a0Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}